Indi (Integrated Diagnostics) is creating powerful new tools to help physicians manage complex diseases with non-invasive blood tests. Our first test, Xpresys Lung, is a molecular blood test developed to provide non-invasive, objective information for assessment of pulmonary nodules. When combined with current clinical assessment, Xpresys Lung may be able to help reduce unnecessary invasive procedures. By reducing these, our objectives are to improve patient outcomes, reduce complications, and lessen the cost to the healthcare system.